Maryland House Bill 920 (Prior Session Legislation)

---

Spectrum: Moderate Partisan Bill (Republican 12-3)
Status: Introduced on February 8 2019 - 25% progression, died in chamber
Action: 2019-04-05 - Unfavorable Report by Health and Government Operations; Withdrawn
Text: Latest bill text (Introduced) [PDF]

Requiring the Secretary of Health, by a certain date each year, to identify a certain number of certain prescription drugs on which the State spends a certain amount of money; requiring the Secretary to require a certain pharmaceutical manufacturer to report certain cost changes and expenditures during a certain period of time; requiring the Secretary, by a certain date each year, to publish a report on the Maryland Department of Health's website based on the information the Secretary receives under certain provisions of the Act; etc.

Health Insurance - Pharmaceutical Manufacturers - Transparency and Reporting

Del. Nicholaus Kipke [R]	Del. Christopher Adams [R]	Del. Carl Anderton [R]	Del. Andrew Cassilly [R]
Sen. Paul Corderman [R]	Del. Jay Jalisi [D]	Del. Steve Johnson [D]	Del. Adrienne Jones [D]
Del. Michael Malone [R]	Del. Susan McComas [R]	Del. Matt Morgan [R]	Del. Teresa Reilly [R]
Del. April Rose [R]	Del. Sid Saab [R]	Del. Kathy Szeliga [R]

Date	Chamber	Action
2019-04-05	House	Unfavorable Report by Health and Government Operations; Withdrawn
2019-02-13	House	Hearing 3/06 at 1:00 p.m.
2019-02-08	House	First Reading Health and Government Operations

Type	Source
Summary	https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/HB0920?ys=2019rs
Text	https://mgaleg.maryland.gov/2019RS/bills/hb/hb0920f.pdf
Supplement	https://mgaleg.maryland.gov/2019RS/fnotes/bil_0000/hb0920.pdf
Supplement	https://mgaleg.maryland.gov/2019RS/votes_comm/hb0920_hgo.pdf